Literature DB >> 11878562

Rhodothermus marinus: a thermophilic bacterium producing dimeric and hexameric citrate synthase isoenzymes.

Karlsson Eva Nordberg1, Maher Abou-Hachem, Olle Holst, Michael J Danson, David W Hough.   

Abstract

Two separate citrate synthases from the extremely thermophilic bacterium Rhodothermus marinus have been identified and purified. One of the enzymes is a hexameric protein and is the first thermostable, hexameric citrate synthase to be isolated. The other is a dimeric enzyme, which is also thermostable but possesses both citrate synthase and 2-methyl citrate synthase activities. 2-Methyl citrate synthase uses propionyl-coenzyme A as one of its substrates and in Escherichia coli, for example, it has been implicated in the metabolism of propionate. However, no growth of R. marinus was observed using minimal medium with propionate as the sole carbon source, and both hexameric and dimeric enzymes were produced irrespective of whether propionate was included in the growth medium. The data are discussed with respect to the evolutionary relationships between the known hexameric and dimeric citrate synthases and 2-methyl citrate synthase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878562     DOI: 10.1007/s007920100226

Source DB:  PubMed          Journal:  Extremophiles        ISSN: 1431-0651            Impact factor:   2.395


  3 in total

Review 1.  Rhodothermus marinus: physiology and molecular biology.

Authors:  Snaedis H Bjornsdottir; Thorarinn Blondal; Gudmundur O Hreggvidsson; Gudmundur Eggertsson; Solveig Petursdottir; Sigridur Hjorleifsdottir; Sigridur H Thorbjarnardottir; Jakob K Kristjansson
Journal:  Extremophiles       Date:  2005-08-02       Impact factor: 2.395

2.  Crystal Structures of Two Isozymes of Citrate Synthase from Sulfolobus tokodaii Strain 7.

Authors:  Midori Murakami; Tsutomu Kouyama
Journal:  Biochem Res Int       Date:  2016-08-30

3.  Cultivation technology development of Rhodothermus marinus DSM 16675.

Authors:  Emanuel Y C Ron; Roya R R Sardari; Richard Anthony; Ed W J van Niel; Gudmundur O Hreggvidsson; Eva Nordberg-Karlsson
Journal:  Extremophiles       Date:  2019-09-14       Impact factor: 2.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.